Ignite Creation Date:
2025-12-24 @ 4:59 PM
Ignite Modification Date:
2025-12-28 @ 6:37 AM
Study NCT ID:
NCT05624450
Status:
RECRUITING
Last Update Posted:
2025-11-17
First Post:
2022-11-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-13
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06-19
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-06-19
Completion Date Type:
ESTIMATED
First Submit Date:
2022-11-11
First Submit QC Date:
None
Study First Post Date:
2022-11-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-13
Last Update Post Date:
2025-11-17
Last Update Post Date Type:
ESTIMATED